EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
3.1.4.4 | lysophosphatidylserine | stimulates PLD activity in a concentration-dependent manner and approximately 5fold and 8fold increases in CYP1A2 and CYP2E1 activities, respectively, are shown in the presence of 2 mol% of the lysophosphatidylserine when compared to a 100% phosphatidylcholine matrix. LysoPS also accompanies conformational changes in both CYP1A2 and CYP2E1 when assayed by circular dichroism | Homo sapiens | |
3.1.4.4 | lysophosphatidylserine | stimulates PLD activity in a concentration-dependent manner and approximately 5fold and 8fold increases in CYP1A2 and CYP2E1 activities, respectively, are shown in the presence of 2 mol% of the lysophosphatidylserine when compared to a 100% phosphatidylcholine matrix. LysoPS also accompanies conformational changes in both CYP1A2 and CYP2E1 when assayed by circular dichroism | Rattus norvegicus |
EC Number | Application | Comment | Organism |
---|---|---|---|
3.1.4.4 | molecular biology | functional roles of CYP1A2 and CYP2E1 can be switched by interaction with a specific anionic lysophospholipid in vivo | Homo sapiens |
3.1.4.4 | molecular biology | functional roles of CYP1A2 and CYP2E1 can be switched by interaction with a specific anionic lysophospholipid in vivo | Rattus norvegicus |
EC Number | Cloned (Comment) | Organism |
---|---|---|
3.1.4.4 | expressed in Escherichia coli | Homo sapiens |
3.1.4.4 | expressed in Escherichia coli | Rattus norvegicus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.1.4.4 | additional information | PLD activity is decreased in the presence of components required for the monooxygenase (MMO) activity (reducing system), including 100% phosphatidylcholine membranes, NADPH-cytochrome P450 reductase and NADPH. Lysophosphatidylserine recoveres the PLD activity in a concentration-dependent manner | Homo sapiens | |
3.1.4.4 | additional information | PLD activity is decreased in the presence of components required for the monooxygenase (MMO) activity (reducing system), including 100% phosphatidylcholine membranes, NADPH-cytochrome P450 reductase and NADPH. Lysophosphatidylserine recoveres the PLD activity in a concentration-dependent manner | Rattus norvegicus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.1.4.4 | Homo sapiens | - |
- |
- |
3.1.4.4 | Rattus norvegicus | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.1.4.4 | using using Ni2+-affinity and ion-exchange chromatography | Homo sapiens |
3.1.4.4 | using using Ni2+-affinity and ion-exchange chromatography | Rattus norvegicus |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.1.4.4 | phosphatidylcholine + H2O | - |
Homo sapiens | choline + phosphatidate | - |
? | |
3.1.4.4 | phosphatidylcholine + H2O | - |
Rattus norvegicus | choline + phosphatidate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.1.4.4 | phospholipase D | - |
Homo sapiens |
3.1.4.4 | phospholipase D | - |
Rattus norvegicus |
3.1.4.4 | PLD | - |
Homo sapiens |
3.1.4.4 | PLD | - |
Rattus norvegicus |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
3.1.4.4 | 37 | - |
assay at | Homo sapiens |
3.1.4.4 | 37 | - |
assay at | Rattus norvegicus |